Emmanuel Chatelus - Concepedia

Author

Emmanuel Chatelus

Also Known As

Benoît Brihaye, Chatelus, Emmanuel, E Chatelus, E. Chatelus, EMMANUEL CHATELUS, Emmanuel CHATELUS, Emmanuel Chatelus, Jorge Juan González Martín, Jérémy Chatelais, Patricia Senet

172

Publications

5.9K

Citations

H-Index

Concepts

All Affiliations

Inserm Université de Strasbourg Université Paris Cité Hôpitaux Universitaires de Strasbourg Assistance Publique – Hôpitaux de Paris

About

Emmanuel Chatelus is an author at Inserm specializing in medicine, rheumatology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	701
2	Health Sciences	1	1	34
3	Public Health	1	1	20
4	Cellular Therapies	1	1	34
5	Epidemiology	1	1	20

Emmanuel Chatelus

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Mapping and predicting mortality from systemic sclerosis Muriel Elhaï, Christophe Meune, Marouane Boubaya, Annals of the Rheumatic Diseases	2017	642
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial Pierre‐Louis Tharaux, Gilles Pialoux, Arthur Pavot, The Lancet Respiratory Medicine	2021	293
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study Jérôme Avouac, Élodie Drumez, É. Hachulla, The Lancet Rheumatology Rheumatoid DisorderRheumatologyAutoimmune DiseaseRheumatic DiseasesImmunology	2021	290
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial François-Xavier Lescure, Hitoshi Honda, Robert Fowler, The Lancet Respiratory Medicine	2021	246
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study) N. Costedoat‐Chalumeau, Lionel Galicier, O. Aumaître, Annals of the Rheumatic Diseases	2012	199
Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study É. Hachulla, Pierre‐Yves Hatron, Patrick Carpentier, Annals of the Rheumatic Diseases	2015	159
B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis Antoine François, Emmanuel Chatelus, Dominique Wachsmann, Arthritis Research & Therapy	2013	140
Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects Lamiae Grimaldi‐Bensouda, Didier Guillemot, Bertrand Godeau, Journal of Internal Medicine	2013	134
Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for Screening Maria Grazia Lazzaroni, Ilaria Cavazzana, Enrico Colombo, The Journal of Rheumatology	2017	125
Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases Renaud Felten, Maxime Dubois, Manuel F. Ugarte‐Gil, The Lancet Rheumatology VaccinationVaccine SafetyRheumatologyAutoimmune DiseaseRheumatic Diseases	2021	123

Page 1